Greater cortical thinning and microstructural integrity loss in myotonic dystrophy type 1 compared to myotonic dystrophy type 2
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Greater cortical thinning and microstructural integrity loss in myotonic dystrophy type 1 compared to myotonic dystrophy type 2 ; volume:271 ; number:8 ; day:19 ; month:6 ; year:2024 ; pages:5525-5540 ; date:8.2024
Journal of neurology ; 271, Heft 8 (19.6.2024), 5525-5540, 8.2024
- Creator
-
Krieger, Britta
Schneider-Gold, Christiane
Genç, Erhan
Güntürkün, Onur
Prehn, Christian
Bellenberg, Barbara
Lukas, Carsten
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00415-024-12511-0
- URN
-
urn:nbn:de:101:1-2410310813302.467475830227
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Krieger, Britta
- Schneider-Gold, Christiane
- Genç, Erhan
- Güntürkün, Onur
- Prehn, Christian
- Bellenberg, Barbara
- Lukas, Carsten
- SpringerLink (Online service)
Other Objects (12)
Myotonic dystrophy and myotonic dystrophy protein kinase : with 1 table
Disease burden of myotonic dystrophy type 1
Myotonic dystrophy type 1: frequency of ophthalmologic findings
Ophthalmological findings in myotonic dystrophy
Myotonic dystrophy type 1 in the COVID-19 era
Endometriosis as Initial Manifestation of Myotonic Dystrophy Type-2
Sigmoid Volvulus in Myotonic Dystrophy Type I (Steinert Disease)
Prevalence and correlates of apathy in myotonic dystrophy type 1
Severe case of myotonic dystrophy type 1 associated with syringomyelia
Plasma microRNAs as biomarkers for myotonic dystrophy type 1
Current Treatment Options for Patients with Myotonic Dystrophy Type 2
Clinical score for early diagnosis of myotonic dystrophy type 2
Myotonic dystrophy and myotonic dystrophy protein kinase : with 1 table
Disease burden of myotonic dystrophy type 1
Myotonic dystrophy type 1: frequency of ophthalmologic findings
Ophthalmological findings in myotonic dystrophy
Myotonic dystrophy type 1 in the COVID-19 era
Endometriosis as Initial Manifestation of Myotonic Dystrophy Type-2
Sigmoid Volvulus in Myotonic Dystrophy Type I (Steinert Disease)
Prevalence and correlates of apathy in myotonic dystrophy type 1
Severe case of myotonic dystrophy type 1 associated with syringomyelia
Plasma microRNAs as biomarkers for myotonic dystrophy type 1
Current Treatment Options for Patients with Myotonic Dystrophy Type 2
Clinical score for early diagnosis of myotonic dystrophy type 2
Myotonic dystrophy and myotonic dystrophy protein kinase : with 1 table
Disease burden of myotonic dystrophy type 1
Myotonic dystrophy type 1: frequency of ophthalmologic findings
Ophthalmological findings in myotonic dystrophy
Myotonic dystrophy type 1 in the COVID-19 era
Endometriosis as Initial Manifestation of Myotonic Dystrophy Type-2
Sigmoid Volvulus in Myotonic Dystrophy Type I (Steinert Disease)
Prevalence and correlates of apathy in myotonic dystrophy type 1
Severe case of myotonic dystrophy type 1 associated with syringomyelia
Plasma microRNAs as biomarkers for myotonic dystrophy type 1
Current Treatment Options for Patients with Myotonic Dystrophy Type 2